Item 7.01 Regulation FD Disclosure
On
The furnishing of the attached presentation is not an admission as to the
materiality of any information therein. The information contained in the slides
is summary information that is intended to be considered in the context of more
complete information included in the Company's filings with the
The information in this Item 7.01 of this Current Report on Form 8-K and Exhibit
99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of
the Exchange Act or otherwise subject to the liabilities of that section or
Sections 11 and 12(a)(2) of the Securities Act. The information contained in
this Item 7.01 and in the presentation attached as Exhibit 99.1 to this Current
Report shall not be incorporated by reference into any filing with the
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description 99.1 Corporate Presentation of4D Molecular Therapeutics, Inc. datedJanuary 10, 2022 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
--------------------------------------------------------------------------------
© Edgar Online, source